ETST Subsidiary, Cannabis Therapeutics Inc., in JV with Smart Medicines GMP plans to launch 2 new Cannabinoid-based pharmaceutical drugs and 3 new advanced Cannabinoid-based nutraceutical products using ETST existing CBD patent, IP and technology.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.